606 related articles for article (PubMed ID: 19453047)
21. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
[TBL] [Abstract][Full Text] [Related]
23. Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumor.
Hsu KH; Yang TM; Shan YS; Lin PW
Am J Surg; 2007 Aug; 194(2):148-52. PubMed ID: 17618793
[TBL] [Abstract][Full Text] [Related]
24. Prognostic analysis of rectal stromal tumors by reference of National Institutes of Health risk categories and immunohistochemical studies.
Tsai MC; Lin JW; Lin SE; Chen HH; Lee CM; Hu TH
Dis Colon Rectum; 2008 Oct; 51(10):1535-43. PubMed ID: 18633679
[TBL] [Abstract][Full Text] [Related]
25. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
26. Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors.
Li CF; Huang WW; Wu JM; Yu SC; Hu TH; Uen YH; Tian YF; Lin CN; Lu D; Fang FM; Huang HY
Clin Cancer Res; 2008 Dec; 14(23):7822-31. PubMed ID: 19047110
[TBL] [Abstract][Full Text] [Related]
27. Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study.
Schneider-Stock R; Boltze C; Lasota J; Peters B; Corless CL; Ruemmele P; Terracciano L; Pross M; Insabato L; Di Vizio D; Iesalnieks I; Dirnhofer S; Hartmann A; Heinrich M; Miettinen M; Roessner A; Tornillo L
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):638-45. PubMed ID: 15701851
[TBL] [Abstract][Full Text] [Related]
28. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.
Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH
Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal stromal tumors--frequency, malignancy, and new prognostic factors: the experience of a single institution.
Bertolini V; Chiaravalli AM; Klersy C; Placidi C; Marchet S; Boni L; Capella C
Pathol Res Pract; 2008; 204(4):219-33. PubMed ID: 18304753
[TBL] [Abstract][Full Text] [Related]
30. The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST.
Shirin H; Kravtsov V; Shahmurov M; Shabat VS; Krinshpon I; Alin A; Avinoach I; Avni Y
Digestion; 2007; 75(1):4-9. PubMed ID: 17406118
[TBL] [Abstract][Full Text] [Related]
31. [Clinical analysis of prognostic factors for patients with gastrointestinal stromal tumors].
Jie ZG; Xie XP; Qin KW; Liu Y; Li ZR; Dai AB; Yao YX
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):210-2. PubMed ID: 16167229
[TBL] [Abstract][Full Text] [Related]
32. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.
Goh BK; Chow PK; Yap WM; Kesavan SM; Song IC; Paul PG; Ooi BS; Chung YF; Wong WK
Ann Surg Oncol; 2008 Aug; 15(8):2153-63. PubMed ID: 18546045
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for survival post surgery for patients with gastrointestinal stromal tumors.
Mrowiec S; Jabłońska B; Liszka L; Pająk J; Leidgens M; Szydło R; Sandecka A; Lampe P
Eur Surg Res; 2012; 48(1):3-9. PubMed ID: 22179138
[TBL] [Abstract][Full Text] [Related]
34. Survival analysis of patients with duodenal gastrointestinal stromal tumors.
Miki Y; Kurokawa Y; Hirao M; Fujitani K; Iwasa Y; Mano M; Nakamori S; Tsujinaka T
J Clin Gastroenterol; 2010 Feb; 44(2):97-101. PubMed ID: 19809358
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors and outcome of resected patients for gastrointestinal stromal tumors.
Chiappa A; Zbar AP; Biffi R; Bertani E; Pace U; Pruneri G; Della Vigna P; Grassi C; Valerio M; Poldi D; Andreoni B
Hepatogastroenterology; 2007; 54(75):693-6. PubMed ID: 17591043
[TBL] [Abstract][Full Text] [Related]
36. [Clinical analysis of 63 cases with gastric gastrointestinal stromal tumors].
Rong L; Wan YL; Nian WD; Liu P; Liang JY
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):24-7. PubMed ID: 19145498
[TBL] [Abstract][Full Text] [Related]
37. Serosal penetration is an important prognostic factor for gastrointestinal stromal tumors.
Vallböhmer D; Marcus HE; Baldus SE; Brabender J; Drebber U; Metzger R; Hölscher AH; Schneider PM
Oncol Rep; 2008 Oct; 20(4):779-83. PubMed ID: 18813818
[TBL] [Abstract][Full Text] [Related]
38. Expression of alpha6 integrin subunit is associated with malignancy in gastric gastrointestinal stromal tumors.
Takeyama H; Funahashi H; Sawai H; Takahashi H; Yamamotorm M; Akamo Y; Manabe T
Med Sci Monit; 2007 Feb; 13(2):CR51-6. PubMed ID: 17261983
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in malignant gastrointestinal stromal tumors.
Muro-Cacho CA; Cantor AB; Morgan M
Ann Clin Lab Sci; 2000 Jul; 30(3):239-47. PubMed ID: 10945563
[TBL] [Abstract][Full Text] [Related]
40. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
